171 related articles for article (PubMed ID: 17938255)
1. The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathways.
de Totero D; Meazza R; Capaia M; Fabbi M; Azzarone B; Balleari E; Gobbi M; Cutrona G; Ferrarini M; Ferrini S
Blood; 2008 Jan; 111(2):517-24. PubMed ID: 17938255
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-21 receptor (IL-21R) is up-regulated by CD40 triggering and mediates proapoptotic signals in chronic lymphocytic leukemia B cells.
de Totero D; Meazza R; Zupo S; Cutrona G; Matis S; Colombo M; Balleari E; Pierri I; Fabbi M; Capaia M; Azzarone B; Gobbi M; Ferrarini M; Ferrini S
Blood; 2006 May; 107(9):3708-15. PubMed ID: 16391014
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of the methylprednisolone-mediated inhibition of NK-cell function: evidence for different susceptibility of IL-2- versus IL-15-activated NK cells.
Chiossone L; Vitale C; Cottalasso F; Moretti S; Azzarone B; Moretta L; Mingari MC
Blood; 2007 May; 109(9):3767-75. PubMed ID: 17234744
[TBL] [Abstract][Full Text] [Related]
4. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
Tyagi A; Agarwal R; Agarwal C
Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
[TBL] [Abstract][Full Text] [Related]
5. Mechanism for IL-15-Driven B Cell Chronic Lymphocytic Leukemia Cycling: Roles for AKT and STAT5 in Modulating Cyclin D2 and DNA Damage Response Proteins.
Gupta R; Li W; Yan XJ; Barrientos J; Kolitz JE; Allen SL; Rai K; Chiorazzi N; Mongini PKA
J Immunol; 2019 May; 202(10):2924-2944. PubMed ID: 30988120
[TBL] [Abstract][Full Text] [Related]
6. Induction of dissociated cytokine profiles by ISRAA with selective critical involvement of ERK1/2 in its signaling functions.
Elhannan S; Taha S; Ben Khalaf N; Bakheit H; Fathallah MD; Bakhiet M
Int J Mol Med; 2015 Dec; 36(6):1583-92. PubMed ID: 26499109
[TBL] [Abstract][Full Text] [Related]
7. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.
Wang LH; Kirken RA; Erwin RA; Yu CR; Farrar WL
J Immunol; 1999 Apr; 162(7):3897-904. PubMed ID: 10201908
[TBL] [Abstract][Full Text] [Related]
8. Mitogenic synergy through multilevel convergence of hepatocyte growth factor and interleukin-4 signaling pathways.
Day RM; Soon L; Breckenridge D; Bridges B; Patel BK; Wang LM; Corey SJ; Bottaro DP
Oncogene; 2002 Mar; 21(14):2201-11. PubMed ID: 11948403
[TBL] [Abstract][Full Text] [Related]
9. IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade.
Ogata A; Chauhan D; Teoh G; Treon SP; Urashima M; Schlossman RL; Anderson KC
J Immunol; 1997 Sep; 159(5):2212-21. PubMed ID: 9278309
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Receptor-Associated Protein Complex Assembly in Interleukin (IL)-2- and IL-15-Activated T-Cell Lines.
Osinalde N; Sanchez-Quiles V; Akimov V; Aloria K; Arizmendi JM; Blagoev B; Kratchmarova I
J Proteome Res; 2017 Jan; 16(1):106-121. PubMed ID: 27463037
[TBL] [Abstract][Full Text] [Related]
11. Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets.
Majka M; Ratajczak J; Villaire G; Kubiczek K; Marquez LA; Janowska-Wieczorek A; Ratajczak MZ
Exp Hematol; 2002 Jul; 30(7):751-60. PubMed ID: 12135673
[TBL] [Abstract][Full Text] [Related]
12. Effect of IL-2R beta-binding cytokines on costimulatory properties of chronic lymphocytic leukaemia cells: implications for immunotherapy.
Spaner DE; Hammond C; Mena J; Shi Y
Br J Haematol; 2004 Dec; 127(5):531-42. PubMed ID: 15566356
[TBL] [Abstract][Full Text] [Related]
13. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.
Petlickovski A; Laurenti L; Li X; Marietti S; Chiusolo P; Sica S; Leone G; Efremov DG
Blood; 2005 Jun; 105(12):4820-7. PubMed ID: 15728130
[TBL] [Abstract][Full Text] [Related]
14. Leflunomide induces apoptosis in fludarabine-resistant and clinically refractory CLL cells.
Dietrich S; Krämer OH; Hahn E; Schäfer C; Giese T; Hess M; Tretter T; Rieger M; Hüllein J; Zenz T; Ho AD; Dreger P; Luft T
Clin Cancer Res; 2012 Jan; 18(2):417-31. PubMed ID: 22072733
[TBL] [Abstract][Full Text] [Related]
15. Shc mediates IL-6 signaling by interacting with gp130 and Jak2 kinase.
Giordano V; De Falco G; Chiari R; Quinto I; Pelicci PG; Bartholomew L; Delmastro P; Gadina M; Scala G
J Immunol; 1997 May; 158(9):4097-103. PubMed ID: 9126968
[TBL] [Abstract][Full Text] [Related]
16. Association of STAT1, STAT3 and STAT5 proteins with the IL-2 receptor involves different subdomains of the IL-2 receptor beta chain.
Delespine-Carmagnat M; Bouvier G; Bertoglio J
Eur J Immunol; 2000 Jan; 30(1):59-68. PubMed ID: 10602027
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the molecular mechanisms underlying growth factor synergy: the role of ERK 2 activation in synergy.
Pearson MA; O'Farrell AM; Dexter TM; Whetton AD; Owen-Lynch PJ; Heyworth CM
Growth Factors; 1998; 15(4):293-306. PubMed ID: 9714913
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-2 Receptor β Thr-450 Phosphorylation Is a Positive Regulator for Receptor Complex Stability and Activation of Signaling Molecules.
Ruiz-Medina BE; Ross JA; Kirken RA
J Biol Chem; 2015 Aug; 290(34):20972-20983. PubMed ID: 26152718
[TBL] [Abstract][Full Text] [Related]
19. Different interleukin 2 receptor beta-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation.
Friedmann MC; Migone TS; Russell SM; Leonard WJ
Proc Natl Acad Sci U S A; 1996 Mar; 93(5):2077-82. PubMed ID: 8700888
[TBL] [Abstract][Full Text] [Related]
20. IL-21 and CD40L signals from autologous T cells can induce antigen-independent proliferation of CLL cells.
Pascutti MF; Jak M; Tromp JM; Derks IA; Remmerswaal EB; Thijssen R; van Attekum MH; van Bochove GG; Luijks DM; Pals ST; van Lier RA; Kater AP; van Oers MH; Eldering E
Blood; 2013 Oct; 122(17):3010-9. PubMed ID: 24014238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
